John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 1,395 shares at $3.13 ($4K) on 2025-09-11, disclosed to the SEC on 2025-09-12.
Open-market sale of $4k SERA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-08-11 | $18K | — | Filing → |